Fampridine Gets Committee Nod With Caveat: Must Study Lower Doses

FDA's Peripheral and Central Nervous System Drugs Advisory Committee recommended further studies of lower doses of Acorda's MS drug fampridine to reduce risk of seizure.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet